Arcaea

What Arcaea does

Arcaea is a Boston-based beauty biotechnology company founded in 2021 that develops novel ingredients and consumer products through what it terms 'Expressive Biology' — a platform combining DNA sequencing, biological engineering, bioinformatics, fermentation, skin biology, and microbiology to access molecules unavailable through traditional chemistry. The company was incubated by Ginkgo Bioworks and operates a dual commercialization model: a B2B ingredients business supplying novel biology-derived actives (such as the ScentARC prebiotic deodorant ingredient launched in March 2023 and Gadusol-derived UV protection acquired in July 2022) to beauty brands, formulation companies, and personal care manufacturers; and a B2C consumer brand, Future Society (launched October 2023), which sells fine fragrances reconstructed from the DNA of extinct flowers. Revenue mechanics are not publicly disclosed but appear to combine ingredient licensing/royalty streams, potential upfront and milestone payments from strategic co-development agreements (notably with OLAPLEX for haircare), and direct-to-consumer e-commerce sales of Future Society fragrances.

The company raised a $78 million Series A in October 2021 from a strategic investor consortium including Chanel, Givaudan, Wittington Ventures, Viking Global, and Cascade, alongside an OLAPLEX strategic investment completed in Q3 2021. Arcaea's target customers span enterprise beauty and personal care brands (deodorant, haircare, sun care, fragrance categories) as primary B2B buyers, with beauty-conscious consumers as the secondary end-market for Future Society. The company is led by MIT-trained chemical engineer Jasmina Aganovic and operates with 11-50 employees from its Boston headquarters. Pricing is not publicly disclosed; ingredient pricing is likely quote-based B2B while Future Society fragrances sell direct through wearefuturesociety.com.

Name

Arcaea

Legal name

ARCAEA LLC

Website

https://arcaea.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Arcaea is a Boston-based biotech company founded in 2021 that develops novel beauty ingredients through DNA sequencing, biological engineering, and fermentation, serving beauty brands via B2B ingredient sales and consumers directly through its Future Society fragrance brand.

Ownership category

akta.pro rank

Product category

Biotechnology Beauty Ingredients

NAICS

Flavoring Syrup and Concentrate Manufacturing (31193), Food Manufacturing (311), Flavoring Syrup and Concentrate Manufacturing (311930)

SIC

Food And Kindred Products (2000), Sugar & Confectionery Products (2060), Fats & Oils (2070)

akta.pro primary industry

Flavors, Fragrances & Aroma Chemicals (IMAEABAE)

akta.pro secondary industries

Flavorings & Extracts (Natural & Artificial) (CRADAOAA), Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)

Keywords

• Biotechnology ingredients
• Beauty formulations
• Fermentation technology
• Consumer fragrances
• Skincare innovation

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Ingredient Sales to Beauty Brands: Supplying novel biology-derived ingredients to the broader beauty industry, providing brands with regenerative and uniquely accessible ingredients for formulation.
2. Consumer Brand Sales (Future Society): Direct-to-consumer sales of fine fragrances and other products under the Future Society brand, recreating scents from extinct flowers using biotechnology.
3. Strategic Partnerships and Co-development: Partnership arrangements with brands like OLAPLEX for haircare innovation, potentially including upfront payments, milestone payments, and ongoing royalties.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels10 records

Core offering

Arcaea develops novel biology-derived ingredients and consumer beauty products using DNA sequencing, biological engineering, bioinformatics, fermentation, and microbiology. The company supplies these ingredients to beauty brands on a B2B basis and operates its own consumer fragrance brand, Future Society, which features scents reconstructed from extinct plants through genetic engineering.

Product overview

Arcaea is a beauty/biotech company building a new foundation for the beauty industry through expressive biology. The company operates a dual business model: (1) as a B2B ingredient supplier developing novel ingredients through DNA sequencing, biological engineering, bioinformatics, fermentation, and skin/microbiology—positioned as an 'ingredient toolset' for the broader beauty industry, and (2) as a consumer brands company creating products uniquely enabled by biology. The portfolio includes the ScentARC ingredient technology (first product for the deodorant category), the Future Society consumer fragrance brand featuring scents from extinct plants, and the acquired Gadusol Labs sun care technology. The company was incubated by Ginkgo Bioworks and leverages their cell engineering platform for biological production.

Differentiator

Problem solved

Functional benefit

Brands

• Future Society: Consumer-facing brand featuring the Scent Surrection Collection: 6 fine fragrances based off DNA sequences of extinct flowers.

Products and services

• Future Society A biology-first consumer fragrance brand featuring scents reconstructed from extinct plants using DNA sequencing and genetic engineering. The inaugural Scent Surrection Collection includes 6 fine fragrances based on DNA sequences of extinct flowers, sold direct-to-consumer via wearefuturesociety.com.
• ScentARC Arcaea's first ingredient technology, a prebiotic active ingredient for the deodorant category targeting odor prevention through microbiome reactivity. Launched in March 2023 for sale to deodorant brands.
• Gadusol-derived UV Protection Technology Sun protective compounds derived from marine life biology, produced through biotechnology. Acquired with Gadusol Laboratories in July 2022, offering superior performance, sustainability, and multi-functionality relative to existing sunscreen benchmarks.
• Arcaea Ingredients Platform B2B ingredient development platform providing novel biology-derived ingredients inaccessible through chemistry alone. Developed through DNA sequencing, biological engineering, bioinformatics, fermentation, and microbiology, sold to beauty brands and used in Arcaea's own consumer products.

Quantifiable outcome

• Biotech skincare market projected to exceed $8.25 billion by 2031
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Gadusol LaboratoriescoreStrategic or Co-development Partner · 20 July 2022Arcaea acquired Gadusol Laboratories, an early-stage company using biotechnology to produce sun protective compounds found in marine life. The acquisition accelerates development of natural sunscreen technology that provides fish-like UV protection, fitting Arcaea's mission to make biology the most desired technology in products.
• OLAPLEXcoreStrategic or Co-development Partner · 28 January 2022Strategic investment and partnership with OLAPLEX, a proven innovator and pioneer in haircare. The transaction was completed in Q3 2021. Partnership focuses on delivering new biotechnology-driven solutions in haircare, leveraging OLAPLEX's expertise and Arcaea's biology platform.
• Ginkgo BioworkscoreTechnology or Integration · 27 October 2021Arcaea was incubated by Ginkgo Bioworks and leverages their biotechnology platform for cell engineering. Ginkgo operates automated labs for high-volume biological engineering, enabling Arcaea to engineer cells to produce target ingredients at scale. This is a foundational partnership for Arcaea's biological engineering capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• dsm-firmenich: Combined nutrition, health, and fragrance/flavor powerhouse. Comparable as a broad incumbent supplying aroma and cosmetic ingredients globally with growing biotech investment.
• Givaudan: World's largest fragrance and flavor house, with its own active biotechnology program and a strategic investment in Arcaea. Comparable as a fragrance ingredient incumbent investing in biotech to defend its category leadership.
• Symrise: Major flavors and fragrances company with significant biotech and cosmetic ingredients portfolio. Comparable as a broad incumbent serving the same beauty industry customer base.
• International Flavors & Fragrances (IFF): Global flavors and fragrances major with broad biotech and fermentation capabilities across health, biosciences, and scent. Comparable as a diversified ingredient incumbent serving beauty and personal care.

Direct peers

• Conagen: Synthetic biology manufacturer producing ingredients via fermentation for flavors, fragrances, cosmetics, and nutrition. Comparable as a B2B biotech ingredient producer serving consumer brands.
• Amyris: Synthetic biology company producing fermentation-derived ingredients for beauty and personal care (including the Biossance skincare brand). Directly comparable as a biology-first beauty ingredient and consumer brand platform.
• Geltor: Biotech company producing animal-free proteins via fermentation for personal care and food. Comparable as a biology-derived specialty ingredient supplier serving beauty brands.

Emerging players

• Codex Beauty: Biotech-focused skincare brand leveraging plant-derived and fermentation-based actives. Comparable as an emerging beauty brand built around biotech ingredient storytelling.

Others

• Ginkgo Bioworks: Synthetic biology platform company and Arcaea's incubator/partner. Comparable as an enabling infrastructure provider rather than a direct competitor; supplies the cell engineering foundry underlying Arcaea's ingredient platform.
• Chanel: Luxury fragrance and beauty house and strategic investor in Arcaea. Comparable as an ecosystem participant — both a potential anchor customer for Arcaea ingredients and an established fragrance competitor to Future Society.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/arcaeabeauty

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcaea